Medicine
Propafenone 150 mg tablet
Propafenone 150 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F),.
Key facts
- Active ingredient (INN)
- Propafenone
- Brand
- Sold under the generic name
- Strength
- 150 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 300 tablets, 100 tablets, 30 tablets and 12 more
- Manufacturers
- Strides PharmaIndiaAurobindo PharmaIndiaBryant Ranch PrepackAmerican Health PackagingANI PharmaceuticalsGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F),.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 April 2004
- Identifiers
- RxCUI 861424, 861427, 861430DailyMed set ID 9da7e6d2-64da-43cd-9575-b2b0d5d412dc, 617faff7-d9e4-477d-ab2c-aded5c129a86, 343e4ad7-05e2-4e6c-8f8e-91c07739cae2 +8NDC 63629-2105, 71335-2780, 60687-709 +8Application ANDA076550, ANDA075938, ANDA202445
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 300 tablet, film coated in 1 bottle, plastic | 64380-165-01 | Strides PharmaIndia | 1 August 2022 |
| 100 tablet, film coated in 1 bottle, plastic | 64380-165-02 | Strides PharmaIndia | 1 August 2022 |
| 300 tablet, film coated in 1 bottle, plastic | 64380-269-01 | Strides PharmaIndia | 5 May 2025 |
| 100 tablet, film coated in 1 bottle, plastic | 64380-269-02 | Strides PharmaIndia | 5 May 2025 |
| 100 tablet, film coated in 1 bottle | 59651-256-01 | Aurobindo PharmaIndia | 25 October 2019 |
| 300 tablet, film coated in 1 bottle | 59651-256-33 | Aurobindo PharmaIndia | 25 October 2019 |
| 100 tablet, coated in 1 bottle | 62559-230-01 | ANI Pharmaceuticals | 31 March 2015 |
| 100 tablet, coated in 1 bottle | 63629-2105-1 | Bryant Ranch Prepack | 29 January 2021 |
| 30 tablet, coated in 1 bottle | 71335-2780-1 | Bryant Ranch Prepack | 13 October 2025 |
| 90 tablet, coated in 1 bottle | 71335-2780-2 | Bryant Ranch Prepack | 13 October 2025 |
| 100 tablet, coated in 1 bottle | 72162-1751-1 | Bryant Ranch Prepack | 30 August 2023 |
| 100 tablet, film coated in 1 bottle | 72162-2616-1 | Bryant Ranch Prepack | 20 April 2026 |
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 60687-709-01 | American Health Packaging | 13 October 2022 |
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 60687-930-01 | American Health Packaging | 21 October 2025 |
| 100 tablet, coated in 1 bottle | 51407-015-01 | Golden State Medical Supply | 8 September 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 November 1989 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Propafenone
Clinical summary
Propafenone is an antiarrhythmic indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease, among other approved uses. MedsAcross supplies Propafenone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PropafenoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- propafenone hydrochloride prescribing information (Northstar Rx) · U.S. National Library of Medicine, DailyMed
Need Propafenone 150 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.